These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22543885)

  • 1. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
    Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
    Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.
    Ampuero J; Del Campo JA; Rojas L; García-Lozano JR; Solá R; Andrade R; Pons JA; Navarro JM; Calleja JL; Buti M; González-Escribano MF; Forns X; Diago M; García-Samaniego J; Romero-Gómez M
    Ann Hepatol; 2014; 13(4):356-63. PubMed ID: 24927606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T
    PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S; Maida M; Grimaudo S; Pipitone RM; Macaluso FS; Cabibi D; Cammà C; Di Marco V; Sferrazza S; Craxì A
    Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.
    Moritou Y; Ikeda F; Iwasaki Y; Baba N; Takaguchi K; Senoh T; Nagano T; Takeuchi Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Yamamoto K
    Acta Med Okayama; 2014; 68(1):17-22. PubMed ID: 24553484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P
    J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.
    Valenti L; Aghemo A; Stättermayer AF; Maggioni P; De Nicola S; Motta BM; Rumi MG; Dongiovanni P; Ferenci P; Colombo M; Fargion S
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
    Cai T; Dufour JF; Muellhaupt B; Gerlach T; Heim M; Moradpour D; Cerny A; Malinverni R; Kaddai V; Bochud M; Negro F; Bochud PY
    J Hepatol; 2011 Sep; 55(3):529-535. PubMed ID: 21236304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.
    Rembeck K; Alsiö A; Christensen PB; Färkkilä M; Langeland N; Buhl MR; Pedersen C; Mørch K; Westin J; Lindh M; Hellstrand K; Norkrans G; Lagging M
    PLoS One; 2012; 7(1):e29370. PubMed ID: 22253715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.
    Wong GL; Chan HL; Tse CH; Chan PO; Cheng JC; Cheng JS; Lau SH; Lee EK; Ma JM; Chan AW; Choi PC; Wong VW
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1040-8. PubMed ID: 25639146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.
    Lin CY; Chen JY; Lin TN; Jeng WJ; Huang CH; Huang CW; Chang SW; Sheen IS
    PLoS One; 2011 Mar; 6(3):e18322. PubMed ID: 21479134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
    Gavril OI; Arhire LI; Gavrilescu O; Dranga M; Barboi O; Gavril RS; Popescu R; Cijevschi Prelipcean C; Trifan AV; Mihai C
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833371
    [No Abstract]   [Full Text] [Related]  

  • 13. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S; Grimaudo S; Cammà C; Cabibi D; Di Marco V; Licata G; Pipitone RM; Craxì A
    J Hepatol; 2012 Jun; 56(6):1356-62. PubMed ID: 22314430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
    PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
    Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
    Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
    Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
    Tillmann HL; Patel K; Muir AJ; Guy CD; Li JH; Lao XQ; Thompson A; Clark PJ; Gardner SD; McHutchison JG; McCarthy JJ
    J Hepatol; 2011 Dec; 55(6):1195-200. PubMed ID: 21703198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.
    Magri MC; Manchiero C; Prata TVG; Nunes AKDS; Oliveira Junior JS; Dantas BP; Tengan FM
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115025. PubMed ID: 32147132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
    Taliani G; Spaziante M; Biliotti E; Borro M; Palazzo D; Grieco S; Franchi C; Iaiani G; Furlan C; Gallinaro V; Simmaco M
    PLoS One; 2013; 8(8):e67301. PubMed ID: 23936294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.